Literature DB >> 22972824

Antimicrobial treatment and containment measures for an extremely drug-resistant Klebsiella pneumoniae ST101 isolate carrying pKPN101-IT, a novel fully sequenced bla(KPC-2) plasmid.

Ilaria Frasson1, Enrico Lavezzo, Elisa Franchin, Stefano Toppo, Luisa Barzon, Antonietta Cavallaro, Sara N Richter, Giorgio Palù.   

Abstract

An extremely drug-resistant Klebsiella pneumoniae isolate, sequence type ST101, was isolated from a patient in Italy. We describe antibiotic treatment, measures to clear and contain the infection, and a complete sequence analysis of a novel large plasmid, pKPN101-IT, harboring the bla(KPC-2) gene and arising from the threatening recombination of different worldwide-distributed backbones.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972824      PMCID: PMC3486238          DOI: 10.1128/JCM.01892-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.

Authors:  Caterina Mammina; Celestino Bonura; Aurora Aleo; Teresa Fasciana; Tamara Brunelli; Giovanna Pesavento; Roberto Degl'Innocenti; Antonino Nastasi
Journal:  Int J Antimicrob Agents       Date:  2012-04-23       Impact factor: 5.283

2.  Molecular epidemiology of KPC-2- producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437.

Authors:  Liliane M Seki; Polyana S Pereira; Maria da Penha A H de Souza; Magda de S Conceição; Elizabeth A Marques; Carlos Oliveira Porto; Elvira Maria L Colnago; Carlene de F M Alves; Deize Gomes; Ana Paula D A Carvalho Assef; Ørjan Samuelsen; Marise D Asensi
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-11       Impact factor: 2.803

3.  Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

Authors:  Spyros Pournaras; Georgia Vrioni; Evangelia Neou; John Dendrinos; Evangelia Dimitroulia; Aggeliki Poulou; Athanassios Tsakris
Journal:  Int J Antimicrob Agents       Date:  2011-01-13       Impact factor: 5.283

4.  First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain.

Authors:  Cristina Pitart; Mar Solé; Ignasi Roca; Anna Fàbrega; Jordi Vila; Francesc Marco
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

5.  Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina.

Authors:  S A Gomez; F G Pasteran; D Faccone; N Tijet; M Rapoport; C Lucero; O Lastovetska; E Albornoz; M Galas; R G Melano; A Corso; A Petroni
Journal:  Clin Microbiol Infect       Date:  2011-08-18       Impact factor: 8.067

6.  Multiplex real-time PCR for detection of an epidemic KPC-producing Klebsiella pneumoniae ST258 clone.

Authors:  Liang Chen; Kalyan D Chavda; José R Mediavilla; Yanan Zhao; Henry S Fraimow; Stephen G Jenkins; Michael H Levi; Tao Hong; Albert D Rojtman; Christine C Ginocchio; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

7.  Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.

Authors:  Zubair A Qureshi; David L Paterson; Brian A Potoski; Mary C Kilayko; Gabriel Sandovsky; Emilia Sordillo; Bruce Polsky; Jennifer M Adams-Haduch; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

8.  KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units.

Authors:  Sara N Richter; Ilaria Frasson; Elisa Franchin; Cristina Bergo; Enrico Lavezzo; Luisa Barzon; Antonietta Cavallaro; Giorgio Palù
Journal:  Gut Pathog       Date:  2012-07-16       Impact factor: 4.181

Review 9.  Current epidemiology and growing resistance of gram-negative pathogens.

Authors:  David M Livermore
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  22 in total

1.  Clinical Performance of a Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method for Detection of Certain blaKPC-Containing Plasmids.

Authors:  Jung-Ho Youn; Steven K Drake; Rebecca A Weingarten; Karen M Frank; John P Dekker; Anna F Lau
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

2.  A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae.

Authors:  Anna F Lau; Honghui Wang; Rebecca A Weingarten; Steven K Drake; Anthony F Suffredini; Mark K Garfield; Yong Chen; Marjan Gucek; Jung-Ho Youn; Frida Stock; Hanna Tso; Jim DeLeo; James J Cimino; Karen M Frank; John P Dekker
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

3.  Tn4401 carrying blaKPC is inserted within another insertion in pKpQIL and related plasmids.

Authors:  Sally R Partridge
Journal:  J Clin Microbiol       Date:  2014-12       Impact factor: 5.948

4.  Complete sequence of a bla(KPC)-harboring cointegrate plasmid isolated from Escherichia coli.

Authors:  Kalyan D Chavda; Liang Chen; Michael R Jacobs; Albert D Rojtman; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

5.  Complete nucleotide sequence of two multidrug-resistant IncR plasmids from Klebsiella pneumoniae.

Authors:  Fabrice Compain; Lionel Frangeul; Laurence Drieux; Charlotte Verdet; Sylvain Brisse; Guillaume Arlet; Dominique Decré
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

6.  Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of KPC-Producing Klebsiella pneumoniae.

Authors:  Paolo Gaibani; Anna Galea; Marco Fagioni; Simone Ambretti; Vittorio Sambri; Maria Paola Landini
Journal:  J Clin Microbiol       Date:  2016-07-13       Impact factor: 5.948

7.  Characterization of KPC-Encoding Plasmids from Enterobacteriaceae Isolated in a Czech Hospital.

Authors:  Rudolf Kukla; Katerina Chudejova; Costas C Papagiannitsis; Matej Medvecky; Katerina Habalova; Lenka Hobzova; Radka Bolehovska; Lenka Pliskova; Jaroslav Hrabak; Helena Zemlickova
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 8.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

9.  Complete sequence of a bla(KPC-2)-harboring IncFII(K1) plasmid from a Klebsiella pneumoniae sequence type 258 strain.

Authors:  Liang Chen; Kalyan D Chavda; Roberto G Melano; Michael R Jacobs; Michael H Levi; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

10.  Comparative analysis of an IncR plasmid carrying armA, blaDHA-1 and qnrB4 from Klebsiella pneumoniae ST37 isolates.

Authors:  Qinglan Guo; Caressa Nicole Spychala; Christi Lee McElheny; Yohei Doi
Journal:  J Antimicrob Chemother       Date:  2016-01-07       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.